SB
Srinivasa Babu Yadala
About Srinivasa Babu Yadala
Data last updated:
Srinivasa Babu Yadala is a Director at Layerly Pharmaceuticals Private Limited (since 2019), Director at Layspan Pharmaceuticals Private Limited (since 2023) and Director at Sarath Meditech Private Limited (since 2022). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Layerly Pharmaceuticals Private Limited at ₹1.68 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Layerly Pharmaceuticals Private Limited U24110TG2019PTC133555 | Director | 20 Jun 2019 | 2019 | ₹1.68 Cr (FY 2022) | Active |
| Layspan Pharmaceuticals Private Limited U46497TS2023PTC176849 | Director | 06 Sep 2023 | 2023 | Active | |
| Sarath Meditech Private Limited U24100TG2022PTC166614 | Director | 13 Sep 2022 | 2022 | Active |
Board colleagues of Srinivasa Babu Yadala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Udaya Kiran Perla | 07313247 | Layerly Pharmaceuticals Private Limited | Managing Director |
| Rama Subrahmanyam Sana | 08342223 | Layspan Pharmaceuticals Private Limited | Director |
| Sri Chandana Modukuri | 07689464 | Sarath Meditech Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasa Babu Yadala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasa Babu Yadala
Srinivasa Babu Yadala currently holds 3 directorships: Layerly Pharmaceuticals Private Limited (Director, since 20 Jun 2019, revenue ₹1.68 Cr (FY 2022)); Layspan Pharmaceuticals Private Limited (Director, since 06 Sep 2023); Sarath Meditech Private Limited (Director, since 13 Sep 2022).
Srinivasa Babu Yadala was first appointed on 20 Jun 2019 as Director at Layerly Pharmaceuticals Private Limited. The most recent appointment on record is 06 Sep 2023 at Layspan Pharmaceuticals Private Limited.
The current boards of Srinivasa Babu Yadala's companies include Udaya Kiran Perla (Layerly Pharmaceuticals Private Limited), Rama Subrahmanyam Sana (Layspan Pharmaceuticals Private Limited), Sri Chandana Modukuri (Sarath Meditech Private Limited).